Evidence map›Paper›PMID 40391199›Full record

ArticleJournal of immunology research2025

The Impact of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen-E, Human Leukocyte Antigen-G Polymorphisms on Innate Immunity and COVID-19 Severity.

Cigdem Kekik, Sonay Temurhan, Yeliz Ogret, Behnoush Nasr Zanjani, Demet Kıvanc, Fatma Savran Oguz, Murat Kose, Fatma Betul Oktelik, Gunnur Deniz

Abstract read
In one paragraph

Article in Journal of immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cigdem KekikTissue Typing Laboratory, Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0003-2098-381X
Sonay TemurhanTissue Typing Laboratory, Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0001-9889-9330
Yeliz OgretTissue Typing Laboratory, Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0001-9732-5474
Behnoush Nasr ZanjaniInstitute of Graduate Studies in Health Science, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0001-6853-4410
Demet KıvancTissue Typing Laboratory, Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0002-2451-5709
Fatma Savran OguzTissue Typing Laboratory, Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0002-6018-8936
Murat KoseDepartment of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0002-7487-9287
Fatma Betul OktelikDepartment of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0002-7994-5618
Gunnur DenizDepartment of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Türkiye.ORCID https://orcid.org/0000-0002-0721-6213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Histocompatibility Antigens Class IHLA-G AntigensKiller Cells, NaturalReceptors, KIRSARS-CoV-2AdultAgedAllelesFemaleGenetic Predisposition to DiseaseGenotypeHLA-E AntigensHumansImmunity, InnateMaleHistocompatibility Antigens Class IHLA-E AntigensHLA-G AntigensReceptors, KIRCOVID-19HLA-G genotypeHuman Leukocyte Antigen-E (HLA-E)killer cell immunoglobulin-like receptor (KIR)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Identifiers

PMID40391199
PMCPMC12088842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.